Search Results
Chronic Lymphocytic Leukemia (CLL) - Etiology, Risk Factors, Symptoms, Signs, Diagnosis, Treatment
Outcomes in high-risk CLL patients following fixed-duration treatment with ibrutinib plus venetoclax
Managing High-Risk CLL
Defining high-risk CLL: known and emerging mutations
Jennifer R. Brown, MD, PhD: The Changing Definition of “High-Risk” CLL
What Does It Mean to Have High-Risk CLL?
Chronic lymphocytic leukemia (CLL): Advances in research & treatment: 2024 Leukemia Conference, LLSC
Dr. Pinilla-Ibarz on Ibrutinib's Efficacy in Treating High-Risk Patients With CLL
Management of High-Risk Chronic Lymphocytic Leukemia
What is High-Risk CLL and How Is It Treated?
Transplantation versus novel therapies in high-risk chronic lymphoblastic leukemia (CLL)?
Embracing Newer Therapies in High-Risk CLL
